Hohlfeld R - Search Results

1

Histopathology and clinical course of MOG-antibody-associated encephalomyelitis.

Spadaro M, Gerdes LA, Mayer MC, Ertl-Wagner B, Laurent S, Krumbholz M, Breithaupt C, Högen T, Straube A, Giese A, Hohlfeld R, Lassmann H, Meinl E, Kümpfel T. Spadaro M, et al. Among authors: hohlfeld r. Ann Clin Transl Neurol. 2015 Mar;2(3):295-301. doi: 10.1002/acn3.164. Epub 2015 Jan 14. Ann Clin Transl Neurol. 2015. PMID: 25815356 Free PMC article.

2

CTLA4 as Immunological Checkpoint in the Development of Multiple Sclerosis.

Gerdes LA, Held K, Beltrán E, Berking C, Prinz JC, Junker A, Tietze JK, Ertl-Wagner B, Straube A, Kümpfel T, Dornmair K, Hohlfeld R. Gerdes LA, et al. Among authors: hohlfeld r. Ann Neurol. 2016 Aug;80(2):294-300. doi: 10.1002/ana.24715. Epub 2016 Jul 15. Ann Neurol. 2016. PMID: 27351142 Free PMC article.

3

Pathogenicity of human antibodies against myelin oligodendrocyte glycoprotein.

Spadaro M, Winklmeier S, Beltrán E, Macrini C, Höftberger R, Schuh E, Thaler FS, Gerdes LA, Laurent S, Gerhards R, Brändle S, Dornmair K, Breithaupt C, Krumbholz M, Moser M, Krishnamoorthy G, Kamp F, Jenne D, Hohlfeld R, Kümpfel T, Lassmann H, Kawakami N, Meinl E. Spadaro M, et al. Among authors: hohlfeld r. Ann Neurol. 2018 Aug;84(2):315-328. doi: 10.1002/ana.25291. Epub 2018 Sep 9. Ann Neurol. 2018. PMID: 30014603

4

B lineage cells in the inflammatory central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulation.

Meinl E, Krumbholz M, Hohlfeld R. Meinl E, et al. Among authors: hohlfeld r. Ann Neurol. 2006 Jun;59(6):880-92. doi: 10.1002/ana.20890. Ann Neurol. 2006. PMID: 16718690 Review.

5

Delayed allergic reaction to natalizumab associated with early formation of neutralizing antibodies.

Krumbholz M, Pellkofer H, Gold R, Hoffmann LA, Hohlfeld R, Kümpfel T. Krumbholz M, et al. Among authors: hohlfeld r. Arch Neurol. 2007 Sep;64(9):1331-3. doi: 10.1001/archneur.64.9.1331. Arch Neurol. 2007. PMID: 17846274

6

Multiple sclerosis. TNFRSF1A, TRAPS and multiple sclerosis.

Kümpfel T, Hohlfeld R. Kümpfel T, et al. Among authors: hohlfeld r. Nat Rev Neurol. 2009 Oct;5(10):528-9. doi: 10.1038/nrneurol.2009.154. Nat Rev Neurol. 2009. PMID: 19794511

7

MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47.

Junker A, Krumbholz M, Eisele S, Mohan H, Augstein F, Bittner R, Lassmann H, Wekerle H, Hohlfeld R, Meinl E. Junker A, et al. Among authors: hohlfeld r. Brain. 2009 Dec;132(Pt 12):3342-52. doi: 10.1093/brain/awp300. Brain. 2009. PMID: 19952055

8

De-escalation from natalizumab in multiple sclerosis: recurrence of disease activity despite switching to glatiramer acetate.

Havla J, Gerdes LA, Meinl I, Krumbholz M, Faber H, Weber F, Pellkofer HL, Hohlfeld R, Kümpfel T. Havla J, et al. Among authors: hohlfeld r. J Neurol. 2011 Sep;258(9):1665-9. doi: 10.1007/s00415-011-5996-y. Epub 2011 Mar 23. J Neurol. 2011. PMID: 21431380

9

Rebound of disease activity after withdrawal of fingolimod (FTY720) treatment.

Havla JB, Pellkofer HL, Meinl I, Gerdes LA, Hohlfeld R, Kümpfel T. Havla JB, et al. Among authors: hohlfeld r. Arch Neurol. 2012 Feb;69(2):262-4. doi: 10.1001/archneurol.2011.1057. Arch Neurol. 2012. PMID: 22332194

10

Viability of autoantibody-targets: how to tackle pathogenetic heterogeneity as an obstacle for treatment of multiple sclerosis.

Mayer MC, Hohlfeld R, Meinl E. Mayer MC, et al. Among authors: hohlfeld r. J Neurol Sci. 2012 Aug 15;319(1-2):2-7. doi: 10.1016/j.jns.2012.05.018. Epub 2012 May 28. J Neurol Sci. 2012. PMID: 22647585 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

431 results

Search Page